Daniel Wood, MD in Aurora, CO - Medicare Urology

Daniel Wood, MD is a medicare enrolled "Urology - Pediatric Urology" physician in Aurora, Colorado. He graduated from medical school in 1994 and has 30 years of diverse experience with area of expertise as Urology. He is a member of the group practice University Physicians Incorporated and his current practice location is 13123 E 16th Ave, Aurora, Colorado. You can reach out to his office (for appointments etc.) via phone at (720) 777-1234.

Daniel Wood is licensed to practice in Colorado (license number TDP.0041935) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1558932384.

Contact Information

	Daniel Wood, MD
	13123 E 16th Ave, Aurora, CO 80045-7106
	(720) 777-1234
	Not Available

Physician's Profile

Full Name	Daniel Wood
Gender	Male
Speciality	Urology
Experience	30 Years
Location	13123 E 16th Ave, Aurora, Colorado
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Daniel Wood graduated from medical school in 1994

NPI Data:

NPI Number: 1558932384
Provider Enumeration Date: 07/02/2021
Last Update Date: 10/20/2021

Medicare PECOS Information:

PECOS PAC ID: 8921496068
Enrollment ID: I20211022001201

Medical Identifiers

Medical identifiers for Daniel Wood such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1558932384	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208800000X	Urology	TDP.0041935 (Colorado)	Secondary
2088P0231X	Urology - Pediatric Urology	TDP.0041935 (Colorado)	Primary

Medical Facilities Affiliation

Facility Name	Location	Facility Type
University Of Colorado Hospital Authority	Aurora, CO	Hospital

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
University Physicians Incorporated	3476465667	2657

News Archive

Sumitomo Dainippon Pharma, SanBio to jointly develop SB623 in the U.S. and Canada

Sumitomo Dainippon Pharma Co., Ltd. and SanBio Co., Ltd., acting through its U.S. subsidiary SanBio, Inc., announced on September 26 that the two companies have entered into a joint development and license agreement for exclusive marketing rights in the U.S. and Canada ("Agreement") for SB623, a cell therapy for the treatment of patients with chronic stroke discovered and currently under development by SanBio.

Hsp90 inhibitors could be effective in treating drug-resistant prostate cancers

Men with aggressive prostate cancer that has stopped responding to conventional treatment could potentially benefit from a new class of cancer drug designed to overcome drug resistance, a new study suggests.

Previously infected vaccinees broadly neutralize SARS-CoV-2 variants of concern

Researchers in the United States have conducted a study demonstrating the effectiveness of first-generation vaccines at protecting against variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals who have previously been infected with the virus.

Study finds childhood obesity increases early signs of cardiovascular disease

At a press conference held today at The Endocrine Society's 91st Annual Meeting in Washington, D.C., Nelly Mauras, M.D., Division Chief of Endocrinology at Nemours Children's Clinic in Jacksonville, announced the results of a four year study with findings that show childhood obesity increases early signs of cardiovascular disease. Dr. Mauras' study was chosen for distinction among 5,000 abstracts that were submitted to the national conference.

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Daniel Wood allows following entities to bill medicare on his behalf.

Entity Name	Denver Health And Hospital Authority
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1477569838 PECOS PAC ID: 4688583578 Enrollment ID: O20031105000211

News Archive

Sumitomo Dainippon Pharma, SanBio to jointly develop SB623 in the U.S. and Canada

Hsp90 inhibitors could be effective in treating drug-resistant prostate cancers

Previously infected vaccinees broadly neutralize SARS-CoV-2 variants of concern

Study finds childhood obesity increases early signs of cardiovascular disease

Entity Name	University Physicians Incorporated
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1962461889 PECOS PAC ID: 3476465667 Enrollment ID: O20031105000375

Sumitomo Dainippon Pharma, SanBio to jointly develop SB623 in the U.S. and Canada

Hsp90 inhibitors could be effective in treating drug-resistant prostate cancers

Previously infected vaccinees broadly neutralize SARS-CoV-2 variants of concern

Study finds childhood obesity increases early signs of cardiovascular disease

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Daniel Wood is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Daniel Wood, MD Po Box 110429, Aurora, CO 80042-0429 Ph: () -	Daniel Wood, MD 13123 E 16th Ave, Aurora, CO 80045-7106 Ph: (720) 777-1234

News Archive

Sumitomo Dainippon Pharma, SanBio to jointly develop SB623 in the U.S. and Canada

Hsp90 inhibitors could be effective in treating drug-resistant prostate cancers

Previously infected vaccinees broadly neutralize SARS-CoV-2 variants of concern

Study finds childhood obesity increases early signs of cardiovascular disease

Urology Doctors in Aurora, CO

Dr. Janine L Oliver, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 12605 E 16th Ave, Aurora, CO 80045 Phone: 720-848-1800
Dr. Michael Anthony Avallone, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 12605 E 16th Ave, Aurora, CO 80045 Phone: 720-848-0000
Brian Flynn, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 12605 E 16th Ave, Aurora, CO 80045 Phone: 720-848-0000
Granville L Lloyd, MD Urology Medicare: Medicare Enrolled Practice Location: 12605 E 16th Ave, University Of Colorado Hospital, Aurora, CO 80045 Phone: 720-848-0000
Vijaya Vemulakonda, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 13123 E 16th Ave, Aurora, CO 80045 Phone: 720-777-1234
Brian Thomas Caldwell, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 13123 E 16th Ave, Box 463, Aurora, CO 80045 Phone: 720-777-1234
Eric Christian Ballon-landa, MD Urology Medicare: Medicare Enrolled Practice Location: 12605 E 16th Ave, Aurora, CO 80045 Phone: 720-848-0000

Daniel Wood, MD - Medicare Urology in Aurora, CO

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medical Facilities Affiliation

Group Practice Association

Sumitomo Dainippon Pharma, SanBio to jointly develop SB623 in the U.S. and Canada

Hsp90 inhibitors could be effective in treating drug-resistant prostate cancers

Previously infected vaccinees broadly neutralize SARS-CoV-2 variants of concern

Study finds childhood obesity increases early signs of cardiovascular disease

Medicare Reassignments

Sumitomo Dainippon Pharma, SanBio to jointly develop SB623 in the U.S. and Canada

Hsp90 inhibitors could be effective in treating drug-resistant prostate cancers

Previously infected vaccinees broadly neutralize SARS-CoV-2 variants of concern

Study finds childhood obesity increases early signs of cardiovascular disease

Sumitomo Dainippon Pharma, SanBio to jointly develop SB623 in the U.S. and Canada

Hsp90 inhibitors could be effective in treating drug-resistant prostate cancers

Previously infected vaccinees broadly neutralize SARS-CoV-2 variants of concern

Study finds childhood obesity increases early signs of cardiovascular disease

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

Sumitomo Dainippon Pharma, SanBio to jointly develop SB623 in the U.S. and Canada

Hsp90 inhibitors could be effective in treating drug-resistant prostate cancers

Previously infected vaccinees broadly neutralize SARS-CoV-2 variants of concern

Study finds childhood obesity increases early signs of cardiovascular disease

Urology Doctors in Aurora, CO